Dobutamine for Management of Surgical Patients With Septic Shock
Key facts
- Who runs it
- First Affiliated Hospital of Zhejiang University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 584 people enrolled
- Started
- 18 Jun 2024
- Ended
- 15 Nov 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- Dobutamine
- Norepinephrine
- Record updated
- 4 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Patients with 18 years or older
- Sugery patients with septic shock and the duration of opration is more than 1 hour
Who cannot take part
- Allergy or known sensitivity to catecholamines(norepinephrine, dobutamine etc.)and genera anesthetics
- Pregnancy
- Long-term intakeβ-receptor blocker
- patietns with dobutamine used within 72h before enrollment
- Patients use Recombinant Human Brain Natriuretic Peptide(rhBNP), Levosimendan and Epinephrine within 72h before enrollment
- Patients with hyperthyroidism
- Patients and guardians refused to participate in this intervention clinical trial
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Septic shock is the last and most severe stage of sepsis and is defined by extremely low blood pressure, despite lots of intravenous fluids. The incidence of septic shock related cardiomyopathy was 10% to 70%. Besides, general anesthesia will inhibit the sympathetic nervous system, reduce myocardial contractility and aggravate cardiac dysfunction. No randomized controlled trials have yet explore the effects of dobutamine on clinical outcomes for patients with septic shock undergoing surgery under general anesthesia.
The 2 groups in the trial
- Dobutamine, norepinephrineTreatment being tested
Patients will be initiated on Dobutamine at 5 mcg/kg/min while continuous infusion of norepinephrine titrated to maintain a mean arterial pressure at 65mmHg or more
Treatment: Dobutamine and Norepinephrine
- NorepinephrineOther group
Norepinephrine was titrated to maintain a mean arterial pressure at 65mmHg or more
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Director, Head of Anesthesiology and Critical Care, Principal Investigator, Professor
- Publications
- Record updated
- 4 December 2025